235 related articles for article (PubMed ID: 38217637)
21. FTO knockout in adipose tissue effectively alleviates hepatic steatosis partially via increasing the secretion of adipocyte-derived IL-6.
Zeng B; Wu R; Chen Y; Chen W; Liu Y; Liao X; Guo G; Wang X
Gene; 2022 Apr; 818():146224. PubMed ID: 35085712
[TBL] [Abstract][Full Text] [Related]
22. Cellular senescence and its role in white adipose tissue.
Smith U; Li Q; Rydén M; Spalding KL
Int J Obes (Lond); 2021 May; 45(5):934-943. PubMed ID: 33510393
[TBL] [Abstract][Full Text] [Related]
23. Drugs against metabolic diseases as potential senotherapeutics for aging-related respiratory diseases.
Matsubayashi S; Ito S; Araya J; Kuwano K
Front Endocrinol (Lausanne); 2023; 14():1079626. PubMed ID: 37077349
[TBL] [Abstract][Full Text] [Related]
24. Activation of GCN2 in macrophages promotes white adipose tissue browning and lipolysis under leucine deprivation.
Wang F; Xiao F; Du L; Niu Y; Yin H; Zhou Z; Jiang X; Jiang H; Yuan F; Liu K; Chen S; Duan S; Guo F
FASEB J; 2021 Jun; 35(6):e21652. PubMed ID: 34004054
[TBL] [Abstract][Full Text] [Related]
25. Monocyte chemoattractant protein-1 secreted by adipose tissue induces direct lipid accumulation in hepatocytes.
Clément S; Juge-Aubry C; Sgroi A; Conzelmann S; Pazienza V; Pittet-Cuenod B; Meier CA; Negro F
Hepatology; 2008 Sep; 48(3):799-807. PubMed ID: 18570214
[TBL] [Abstract][Full Text] [Related]
26. Multi-tissue profiling of oxylipins reveal a conserved up-regulation of epoxide:diol ratio that associates with white adipose tissue inflammation and liver steatosis in obesity.
Hateley C; Olona A; Halliday L; Edin ML; Ko JH; Forlano R; Terra X; Lih FB; Beltrán-Debón R; Manousou P; Purkayastha S; Moorthy K; Thursz MR; Zhang G; Goldin RD; Zeldin DC; Petretto E; Behmoaras J
EBioMedicine; 2024 May; 103():105127. PubMed ID: 38677183
[TBL] [Abstract][Full Text] [Related]
27. The Novel Lipid-Lowering Drug D-47 Ameliorates Hepatic Steatosis and Promotes Brown/Beige-Like Change of White Adipose Tissue in db/db Mice.
Mizusaki N; Nomura K; Hosooka T; Shiomi M; Ogawa K; Tsunoda T; Tamori Y; Ogawa W
Kobe J Med Sci; 2019 Jun; 65(1):E36-E43. PubMed ID: 31341155
[TBL] [Abstract][Full Text] [Related]
28. PDGFRβ + cell HIF2α is dispensable for white adipose tissue metabolic remodeling and hepatic lipid accumulation in obese mice.
Yao T; Wei D; Tian X; Zhao L; Wan Q; Zhang X; Cai J; Li S; Diao B; Feng S; Shan B; Shao M; Wu Y
Lipids Health Dis; 2024 Mar; 23(1):81. PubMed ID: 38509584
[TBL] [Abstract][Full Text] [Related]
29. Senolytics and senomorphics: Natural and synthetic therapeutics in the treatment of aging and chronic diseases.
Lagoumtzi SM; Chondrogianni N
Free Radic Biol Med; 2021 Aug; 171():169-190. PubMed ID: 33989756
[TBL] [Abstract][Full Text] [Related]
30. CLSTN3 gene variant associates with obesity risk and contributes to dysfunction in white adipose tissue.
Bai N; Lu X; Jin L; Alimujiang M; Ma J; Hu F; Xu Y; Sun J; Xu J; Zhang R; Han J; Hu C; Yang Y
Mol Metab; 2022 Sep; 63():101531. PubMed ID: 35753632
[TBL] [Abstract][Full Text] [Related]
31. Adipose-Specific Deficiency of Fumarate Hydratase in Mice Protects Against Obesity, Hepatic Steatosis, and Insulin Resistance.
Yang H; Wu JW; Wang SP; Severi I; Sartini L; Frizzell N; Cinti S; Yang G; Mitchell GA
Diabetes; 2016 Nov; 65(11):3396-3409. PubMed ID: 27554470
[TBL] [Abstract][Full Text] [Related]
32. Berardinelli-Seip congenital lipodystrophy 2 regulates adipocyte lipolysis, browning, and energy balance in adult animals.
Zhou H; Lei X; Benson T; Mintz J; Xu X; Harris RB; Weintraub NL; Wang X; Chen W
J Lipid Res; 2015 Oct; 56(10):1912-25. PubMed ID: 26269358
[TBL] [Abstract][Full Text] [Related]
33. Sympathetic overdrive and unrestrained adipose lipolysis drive alcohol-induced hepatic steatosis in rodents.
Zhou C; Ruiz HH; Ling L; Maurizi G; Sakamoto K; Liberini CG; Wang L; Stanley A; Egritag HE; Sanz SM; Lindtner C; Butera MA; Buettner C
Mol Metab; 2023 Dec; 78():101813. PubMed ID: 37777008
[TBL] [Abstract][Full Text] [Related]
34. Obesity, Senescence, and Senolytics.
Chaib S; Tchkonia T; Kirkland JL
Handb Exp Pharmacol; 2022; 274():165-180. PubMed ID: 34697668
[TBL] [Abstract][Full Text] [Related]
35. mTORC1 inhibition uncouples lipolysis and thermogenesis in white adipose tissue to contribute to alcoholic liver disease.
Song Q; Chen Y; Ding Q; Griffiths A; Liu L; Park J; Liew CW; Nieto N; Li S; Dou X; Jiang Y; Song Z
Hepatol Commun; 2023 Mar; 7(3):e0059. PubMed ID: 36757400
[TBL] [Abstract][Full Text] [Related]
36. Growth hormone action predicts age-related white adipose tissue dysfunction and senescent cell burden in mice.
Stout MB; Tchkonia T; Pirtskhalava T; Palmer AK; List EO; Berryman DE; Lubbers ER; Escande C; Spong A; Masternak MM; Oberg AL; LeBrasseur NK; Miller RA; Kopchick JJ; Bartke A; Kirkland JL
Aging (Albany NY); 2014 Jul; 6(7):575-86. PubMed ID: 25063774
[TBL] [Abstract][Full Text] [Related]
37. Growth Hormone Receptor Antagonist Transgenic Mice Have Increased Subcutaneous Adipose Tissue Mass, Altered Glucose Homeostasis and No Change in White Adipose Tissue Cellular Senescence.
Comisford R; Lubbers ER; Householder LA; Suer O; Tchkonia T; Kirkland JL; List EO; Kopchick JJ; Berryman DE
Gerontology; 2016; 62(2):163-72. PubMed ID: 26372907
[TBL] [Abstract][Full Text] [Related]
38. Senotherapy, cancer, and aging.
Balducci L; Falandry C; Silvio Monfardini
J Geriatr Oncol; 2024 May; 15(4):101671. PubMed ID: 37977898
[TBL] [Abstract][Full Text] [Related]
39. Senotherapeutics in Cancer and HIV.
Sánchez-Díaz L; Espinosa-Sánchez A; Blanco JR; Carnero A
Cells; 2022 Apr; 11(7):. PubMed ID: 35406785
[TBL] [Abstract][Full Text] [Related]
40. Exploring the fuzzy border between senolytics and senomorphics with chemoinformatics and systems pharmacology.
Olascoaga-Del Angel KS; Gutierrez H; Königsberg M; Pérez-Villanueva J; López-Diazguerrero NE
Biogerontology; 2022 Aug; 23(4):453-471. PubMed ID: 35781578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
